Non-Licensed Products Sample Clauses

Non-Licensed Products. Subject to the terms and conditions of this Agreement, with respect to each Discontinued Antigen, ABX and its Affiliates hereby grant to AZ the (a) non-exclusive, worldwide right and license (with the right to grant sublicenses through multiple tiers of sublicensees as provided in Section 4.5.3) under ABX’s right, title and interest in and to the Collaboration Patent Rights and Collaboration Know-How Rights applicable to such Discontinued Antigen (and under the Licensed ABX IP Rights solely to the extent necessary to enable AZ to utilize Collaboration Technology applicable to such Discontinued Antigen) to Exploit all Non-Licensed Products (other than Non-Antibody Products), and (b) exclusive, worldwide right and license (with the right to grant sublicenses through multiple tiers of sublicensees) under ABX’s right, title and interest in and to the Collaboration Patent Rights and Collaboration Know-How Rights and the ABX Prior Antigen-Specific Know-How Rights and ABX Prior Antigen-Specific Patent Rights applicable to such Discontinued Antigen (and under the Licensed ABX IP Rights solely to the extent necessary to enable AZ to utilize Collaboration Technology and Antigen-Specific Technology applicable to such Discontinued Antigen) to Exploit Non-Antibody Products, in each case with respect to such Discontinued Antigen for use in the Commercial Field; provided, however, that the license grant under clause (b) above with respect to the ABX Prior Antigen-Specific Know-How Rights and ABX Prior Antigen-Specific Patent Rights is subject to the financial terms agreed to by the Parties pursuant to the last sentence of Section 4.4.1(a).
Sample 1Sample 2
AutoNDA by SimpleDocs
Non-Licensed Products. Subject to the terms and conditions of this Agreement including all of the license grants set forth in Article 4, AZ shall have the exclusive right to Exploit Non-Antibody Products with respect to each Collaboration Antigen (including Discontinued Antigens and Failed Antigens) and, upon the delivery of an Election Notice with respect to a Collaboration Antigen, all other Non-Licensed Products with respect to such Collaboration Antigen, which Exploitation in each case may be performed by AZ or with or through one or more Affiliates or Third Parties throughout the world. For purposes of clarity, nothing in this Section 5.10 is intended to expand the scope of the license grants expressly set forth in Article 4.
Sample 1Sample 2
Non-Licensed Products. The term "Non-Licensed Products" shall have --------------------- the meaning set forth in Section 5.4.
Sample 1
Non-Licensed Products. Data I/O retains the right to license XXXX and ECS in accordance with Section 9.7 above.
Sample 1

Related to Non-Licensed Products

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Sublicensees Licensee shall have the full right (but not the obligation) to sublicense those rights granted to it under Section 2.1 to a Third Party (a “Sublicensee”); provided, however, that, prior to the payment of the first milestone pursuant to Section 7.2, Licensee may not grant any such sublicense to any contract research organization conducting Clinical Trials of Products or any Third Parties conducting contract Manufacturing activities without Licensee’s prior written notice (at least twenty (20) Business Days in advance) to Lilly, which shall include a description of the rights to be granted and the purpose therefor, the identity of the Third Party and the countries involved, and Lilly’s prior written consent, but such consent shall only be required (i) until such time as Licensee is the holder of record for the Regulatory Materials related to Taladegib and (ii) to the extent such organization is not performing services for Licensee as of the Effective Date; and provided further, that Licensee shall remain responsible for the performance by any of its Sublicensees. With respect to any Sublicensee granted a sublicense to any Commercialization rights hereunder, Licensee shall ensure that each of its Sublicensees accepts in writing all applicable terms and conditions of this Agreement, including the non-compete, reporting, audit, inspection and confidentiality provisions hereunder. Each Sublicensee shall also be prohibited from further sublicensing. For the avoidance of doubt, (a) Licensee will remain directly responsible for all amounts owed to Lilly under this Agreement, and (b) each Sublicensee is subject to the negative and restrictive covenants set forth in Sections 2.3.1 and 2.5, respectively. Licensee hereby expressly waives any requirement that Lilly exhaust any right, power or remedy, or proceed against a subcontractor, for any obligation or performance hereunder prior to proceeding directly against Licensee.

  • Product The term “

Time is Money Join Law Insider Premium to draft better contracts faster.